Kirk Mendez, MD
Orthopaedic Surgery · Las Vegas, NVNPI 1861693855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 74.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $346 and has fallen 55.9% since, to $153 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NV, where the typical reported total is $3,547.
Across 32 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$643
- Goode Surgical Inc$132
- Johnson & Johnson$36
- Stryker$25
- Acera Surgical, Inc.$19
- Dynasplint Systems Inc.$14
What the payments were for
- Food & beverage$869100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 21 | $643 |
| Goode Surgical Inc | 6 | $132 |
| Johnson & Johnson(2 entities) | 2 | $36 |
| Stryker | 1 | $25 |
| Acera Surgical, Inc. | 1 | $19 |
| Dynasplint Systems Inc. | 1 | $14 |
How this compares
$869 in reported general payments places this provider in the 25th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $256 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Las Vegas
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
- Ronald HillockLas Vegas$275K
- Galen KamLas Vegas$270K
- Michael DaubsLas Vegas$215K
- John BaldaufLas Vegas$117K
- Brian CarrLas Vegas$91K
- Brandon RomeroLas Vegas$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.